T cell anergy is one of the major mechanisms to maintain peripheral T cell tolerance. T cell anergy is induced by TCR engagement without appropriate costimulatory activation (1) (2) (3) (4) . T cell anergy could be generated in vitro by disproportional induction of calcium signaling and activation of NFAT (5, 6) . Downstream of NFAT, several E3 ubiquitin ligases, including Casitas B-lineage lymphoma (Cbl-b), Itch, and the gene related to anergy in lymphocyte (GRAIL; ring finger protein 128), are upregulated in anergic T cells (2, (6) (7) (8) . The physiological role of these E3 ligases in the regulation of T cell activation and the control of autoimmunity has been demonstrated in mice with genetic inactivation of each E3 ligase (9) (10) (11) (12) (13) . One mechanism by which these anergy-inducible E3 ligases promote T cell anergy is by ubiquitination and/or degradation of T cell signaling molecules. For example, Cbl-b induces the ubiquitination of the p85 subunit of PI3K to prevent the recruitment of p85 by CD28 (14) . Itch induces monoubiquitination of phospholipase C-g (PLC-g) to target the lysosome for degradation (7) . Both Cbl-b and Itch promote protein kinase Cu (PKCu) degradation in anergic Th1 cells (7) . Notably, there is a bidirectional interaction between Cbl-b and PKCu, as PKCu also targets Cbl-b for ubiquitination and degradation (15) . Many of the molecular processes involved in maintenance of T cell anergy by these E3 ligases remain incompletely understood. For example, only recently was the indispensable role of RING finger E3 ligase activity of Cbl-b in in vivo tolerance confirmed (16) .
Deltex (DTX) is a target of Notch and composed of Notchbinding WWE domains at the N terminus, followed by a proline-rich motif and a C-terminal RING finger domain (17, 18) . DTX1 confers ligand-independent activation of Notch by directing the ubiquitination and endosomal entry of Notch (19) (20) (21) . We recently identified DTX1 as another target of NFAT and showed that it is induced during T cell anergy (22, 23) . Knockout of DTX1 eliminates restriction in T cell activation, confers resistance to anergy induction, and results in generation of autoimmune syndromes in mice (23) . DTX1 promotes the degradation of MEK kinase 1 and stimulates the expression of Cbl-b and GADD45b (23) . In the current study, we found that DTX1 also targets PKCu for degradation. Similar to Cbl-b, DTX1 interacted with PKCu. In Dtx1 2/2 T cells, anergy-induced downregulation of PKCu was impaired. In addition, there was interaction between DTX1 and Cbl-b. DTX1 increased Cbl-b protein expression partly through antagonizing PKCu-mediated Cbl-b degradation. Our results suggest a novel crosstalk of DTX1 with Cbl-b in T cell anergy; both DTX1 and Cbl-b promote PKCu downregulation, whereas DTX1 further enhances Cbl-b expression by preventing PKCu-directed Cbl-b proteolysis.
Materials and Methods

Reagents
Mouse DTX1 cDNA (18) was a gift from Dr. Hideyuki Okano (Keiko University, Tokyo, Japan). DTX1 mutants were generated as described previously (22, 23) . Full-length PKCu and Cbl-b cDNA was generated from mRNA of murine CD4 + T cell and cloned into pcDNA4-Myc-His-A and pIRES-hrGFP-1a expression vector to yield Myc-tagged and Flag-tagged proteins. Calcium ionophore (A23187), MG132, 3-methyladenine (3-MA), and anti-Flag-HRP were purchased from Sigma-Aldrich (St. Louis, MO). Rabbit anti-DTX1 polyclonal antiserum was generated by raising Abs against GST-DTX1. 
Cell culture and transfection
T cells were cultured in RPMI 1640 medium supplemented with 10% FCS (both from Life Technologies), 10 mM glutamine, 100 U/ml penicillin, 100 U/ml streptomycin, and 20 mM 2-ME. DMEM (Life Technologies) was used in the culture of 293T cells. Transfection of 293T cells was performed by using OmicsFect In Vitro Transfection Reagent (Omics Biotechnology, Taiwan, Republic of China). Transfection of Jurkat T cells was conducted by electroporation on a Neon Transfection System (Invitrogen, Carlsbad, CA) at 1450 V, 30 ms, one pulse.
Th1 cells and anergy induction
Splenic CD4
+ T cells (1 3 10 6 /well) were activated with plate-bound 5 mg/ml anti-CD3 (2C11) and 2.5 mg/ml anti-CD28 (37.51) in the presence of anti-IL-4 (5 mg/ml, 11B11; BioLegend, San Diego, CA), mouse IL-2 (10 ng/ml, R&D Systems, Minneapolis, MN), and mouse IL-12 (10 ng/ml; R&D Systems) in 12-well plates for 5 d. Cells were then washed and cultured in the presence of 10 ng/ml IL-2 for another 2 d. For anergy induction, Th1 cells were treated with 100 ng/ml A23187 for 16 h. IL-2 production was measured by [ 3 H]thymidine incorporation into IL-2-dependent HT-2 cells. Anergy induction in Jurkat cells was achieved by treatment with A23187 (1 mg/ml).
Short hairpin RNA knockdown
Short hairpin RNA (shRNA) constructs containing target sequences were cloned into pLentiLox vector (pLL3.7; gift from Dr. Luk Van Parijs, Massachusetts Institute of Technology, Cambridge, MA). The shRNA sequences were as follows: human DTX1, 59-GAA GTT CAC CGC AAG AGG A-39; human Cbl-b, 59-ATC TTC AGT CAC ATG CTG GCA G-39; human Itch, 59-AAG TGC TTC TCA GAA TGA TGA-39; and human PKCu, 59-GAG TAT GTC GAA TCA GAG A-39. Lentiviruses were harvested from culture supernatants of HEK293T cells transfected with pLL3.7 (12 mg), psPAX2 (9 mg), and pMD2.G (4 mg) for 48 h. Jurkat cells were infected with recombinant lentivirus, and GFP-expressing cells were isolated 48 h postinfection by sorting on an FACSAria II SORP (BD Biosciences). The human DTX1 sequence targeted by shRNA differs from the corresponding mouse DTX1 sequence by three nucleotides. We thus used murine DTX1 to reconstitute DTX1 expression in DTX1-knockdown Jurkat cells.
Immunoprecipitation
Cells were washed twice with PBS buffer and lysed in whole-cell extract (WCE) buffer (25 mM HEPES [pH 7.4], 300 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA [pH 8], 0.1% Triton X-100, 0.5 mM DTT, and 13 complete protease inhibitor [EDTA-free; Roche]). For monoubiquitination detection, N-ethylmaleimide (20 mM) was included in WCE buffer. Whole-cell lysates (250 mg) were incubated with primary Abs overnight at 4˚C. Protein G Mag Sepharose (5 ml; GE Healthcare, Piscataway, NJ) were added, and the samples were incubated at 4˚C for 1 h. Protein G Mag Sepharose was washed repeatedly with 1 ml WCE buffer. The beads were mixed with 13 SDS-PAGE sample buffer and boiled at 100˚C for 5 min. Pulldown complex and total lysates were resolved by 10% SDS-PAGE and transferred to polyvinylidene difluoride membranes (Millipore). The membranes were blocked with 5% skim milk for 1 h and probed with an appropriate Ab, followed by incubation with an HRP-conjugated secondary Ab. The protein bands were visualized by the ECL detection system.
Fluorescence protein expression
pmRFP-Rab5, pPSmOrange-tubulin, LAMP1-RFP, and pFPV-mCherry were obtained from Addgene. The enhanced (EGFP) coding fragment was subcloned into pcDNA4-DTX1-Myc to create the fusion construct pcDNA4-EGFP-DTX1. The mOrange coding fragment was subcloned into pcDNA4-PKCu-Myc to generate fusion protein construct pcDNA4-mOrange-PKCu. LAMP1 and mCherry encoding regions were cloned into pcDNA4-Myc/His-A to create a LAMP1 fusion protein construct pcDNA4-LAMP1-mCherry. Jurkat cells were transfected with mRFP-Rab5, LAMP1-mCherry, mOrange-PKCu, EGFP-DTX1, or EGFP-DTX1 (proline-rich region [ΔPR]). mOrange-positive cells were sorted on an FACSAria II SORP (BD Biosciences) 24 h later and then reseeded on 22 3 22 mm polylysinecoated glass coverslips and allowed to attach for another 18 h. Cells were fixed in 2% paraformaldehyde in PBS for 15 min at 37˚C and permeabilized with 0.3% Triton X-100 for 10 min at room temperature. Cells were mounted in Dapi-Fluoromount-G (Southern Biotechnology Associates).
Image acquisition
Cells were observed under a Zeiss LSM 780 confocal microscope (Zeiss) with an objective lens of plan-Apochromat 633/1.4 Oil differential interference contrast at room temperature. EGFP fluorescence protein was excited by the Argon-Laser (488 nm), and fluorescence was collected in the range of 490 to 550 nm. mOrange fluorescence protein was excited by the DPSS-Laser (561 nm), and fluorescence was collected in the range of 565 to 580 nm. mRFP and mCherry fluorescence protein were excited by the HeNe-Laser (594 nm), and the emission was collected with 545 nm long-pass filter. DAPI-bound DNA was excited by the diode laser (405 nm), and fluorescence was collected in the range of 405 to 470 nm. The pinholes were as follows: Ch1-4.9 mm (blue), Ch2-10.1 mm (orange), Chs1-8.1 mm (green), and GaAsP2-8.1 mm (red). Images were acquired by an AxioCam digital microscope camera (Zeiss) using Carl Zeiss software Zen 2010B SP1. Colocalization and intensity quantification were performed with intensity correlation coefficient using WCIF ImageJ software. Each individual cell was gated by ImageJ selection tool, and Pearson correlation coefficient between mOrange and mRFP (or mCherrY) fluorescence was measured. A Pearson correlation coefficient value of 0 indicates nonoverlappng image, and a value of 1 represents 100% colocalization. Thirty individual cells were measured.
Results
DTX1 deficiency prevents PKCu downregulation in anergic Jurkat cells
We examined the potential role of DTX1 in the expression of signaling proteins in anegic T cells. Jurkat T cells were treated with calcium ionophores to induce T cell anergy. A23187 priming led to downregulation of PKCu in Jurkat cells (Fig. 1A ), similar to a previous report in anergic Th1 cells (7) . A decrease in PLC-g1 in anergic Jurkat cells was also observed (Fig. 1 ). The levels of Zap70 and SLP76, in contrast, were not affected by anergy induction. Knockdown of DTX1 by specific shRNA in Jurkat cells prevented A23187-induced PKCu degradation (Fig. 1A) . Calcium ionophore-mediated PLC-g1 downregulation was also reversed by DTX1 deficiency in Jurkat cells. To further confirm the specific role of DTX1, mouse DTX1 was reintroduced into DTX1-knockdown Jurkat cells. Fig. 1B illustrates that reconstitution of DTX1 in DTX1-deficient Jurkat cells restored the sensitivity of PKCu to A23187-triggered degradation. These results suggest that, analogous to the other two anergy-associated E3 ligases Cblb and Itch, DTX1 may also regulate the expression of PKCu and PLC-g1 in anergic T cells. Notably, the expression levels of the transfected DTX1, which did not contain Dtx1 promoter, were increased in T cells treated with A23187 (Fig. 1B) . Protein stability analysis illustrated that calcium signaling also increased the protein stability and t 1/2 of the transfected DTX1 in DTX1-knockdown Jurkat cells (Supplemental Fig. 1 ). Therefore, in anergic T cell induced by calcium, Dtx1 transcripts are induced by Ca 2+ -NFAT axis (23), whereas DTX1 proteins are further stabilized by calcium signaling.
DTX1 interacts with PKCu and promotes PKCu degradation
We examined whether DTX1 promoted PKCu protein degradation. Coexpression of DTX1 with PKCu led to reduction of PKCu levels in 293T cells (Fig. 1C) . DTX1 also decreased the expres-sion of PLC-g1 when cotransfected with PLC-g1 into 293T cells (Supplemental Fig. 2A ). Further, we found an association between DTX1 and PKCu ( Fig. 2) . In immunoprecipitation analysis, the Ab against DTX1-myc brought down PKCu. A DTX1-PLC-g1 interaction was similarly found (Supplemental Fig. 2B ). Because DTX1 exhibited similar effects on PKCu and PLC-g1, only the inhibitory effects of DTX1 on PKCu were examined in detail in the current study. By using DTX1 mutants with deletion at the Nterminal two WWE domains (ΔN2), ΔPR, or the RING finger domain (ΔRF) (Fig. 2) , we delineated the domains involved in such interaction in Jurkat cells. Both DTX1ΔN2 and DTX1ΔRF interacted with PKCu in Jurkat cells, implying that either the WWE domains or RF domain is not involved in the binding of DTX1 to PKCu (Fig. 2) . In contrast, DTX1ΔPR did not bind PKCu, suggesting that proline-rich domain is the PKCu-binding region on DTX1. The functional role of DTX1 PR domain was also illustrated by that reconstitution of DTX1ΔPR failed to restore the ability of A23187 to downregulate PKCu in DTX1- deficient Jurkat cells (Fig. 1D) . For PKCu, the kinase domaincontaining C terminus was found to inteact with DTX1 (Supplemental Fig. 3 ). However, binding to DTX1 could also be detected in PKCuΔ kinase domain (Supplemental Fig. 3 ), suggesting the presence of additional region(s) on PKCu that interact with DTX1.
DTX1 promotes PKCu degradation likely by the endosomelysosome pathway
We next examined how DTX1 promoted the downregulation of PKCu. PKCu is subjected to monoubiquitination in anergic T cells (7), whereas DTX1 is known to promote Notch monoubiquitination (21) . Fig. 3A illustrate that the monoubiquitination of PKCu became prominent in Jurkat cells upon anergy induction by A23187 treatment. Coexpression of DTX1 with PKCu also induced the monoubiquitination of PKCu in 293T cells (Fig. 3B) . We investigated whether DTX1 increased A23187-triggered PKCu monoubiquitination. A23187-induced PKCu monoubiquitination in Jurkat cells was further enhanced by the additional expression of DTX1, as well as by Cbl-b or Itch (Fig. 3C) . To examine the contribution of the endogenous DTX1 to PKCu monoubiquitination, we further used Jurkat cells deficient in DTX1, Cbl-b, or Itch (Supplemental Fig. 4A ). Downregulation of DTX1 reduced monoubiquitination of PKCu in A23187-treated Jurkat cells, in extents comparable to those observed by knockdown of either Cbl-b or Itch (Fig. 3D) . Consistent with the decrease in PKCu monoubiquitination, A23187-induced PKCu degradation was largely prevented by downregulation of DTX1, Cbl-b, or Itch in Jurkat cells (Fig. 3D) . We also found that DTX1-mediated PKCu degradation was not inhibited by inclusion of MG132 (Fig. 3E) , suggesting a process that is proteasome independent. Addition of 3-MA, an inhibitor of autophagy, did not interfere with DTX1-directed PKCu degradation either (Fig. 3E) . In contrast, the inclusion of NH 4 Cl or chloroquine, inhibitors of endosome and lysosome pathways, effectively prevented DTX1-induced PKCu degradation in Jurkat cells (Fig. 3F) .
Monoubiquitination modification is often associated with directing of protein into endosomal-lysosomal vesicles, a process found in DTX1-mediated targeting of Notch to endosomal compartments (21) . We therefore examined whether DTX1 also directed PKCu into the lysosomal pathway in Jurkat T cells. Fig. 4A illustrates that expression of PKCu by itself did not lead to apparent colocalization with the early endosomal marker Rab5. Coexpression of DTX1 with PKCu resulted in substantial colocalization of Rab5 and PKCu in Jurkat cells. In contrast, DTX1ΔPR failed to direct PKCu into Rab5-containing compartments (Fig. 4A) , suggesting that entry of PKCu into endosomal compartments is promoted by the PKCu-DTX1 association. Similarly, PKCu was not located in lysosomes when expressed alone, yet the presence of DTX1 enhanced the colocalization of PKCu with lysosomal marker LAMP1 in Jurkat cells (Fig. 4B) . The removal of PR domain from DTX1 impaired its capacity to promote PKCu into LAMP1 + compartments (Fig. 4B) . Quantitative analysis illustrates the effect of DTX1, but not DTX1ΔPR, in promoting the colocalization of PKCu with and Rab5 and LAMP1 in T cells (Fig. 4C) . Together, these results suggest that DTX1, analogous to Cbl-b and Itch (7), directs PKCu into endosomal and lysosomal compartments. (Fig. 5A ). As previously reported (7, 13) , PKCu levels remained unchanged in WT and Dtx1 2/2 primary Th1 cells after A23187 treatment (Fig. 5B ).
DTX1 is essential for downregulation of PKCu in anergic primary Th1 cells
Previous studies have demonstrated that either Cbl-b or Itch is required for PKCu degradation in anergic Th1 cells, as shown by the resistance of PKCu to ionomycin-induced downregulation in
Only after TCR ligation did the decrease of PKCu become prominent in anergic primary Th1 cells (7), as shown in Fig. 5B . DTX1 deficiency prevented TCR-stimulated PKCu downregulation in anergic primary Th1 cells (Fig. 5B) . Therefore, DTX1 is also essential for PKCu degradation in anergic normal T cells.
DTX1 interacts with Cbl-b and increases the stability of Cbl-b protein
We have previously demonstrated that DTX1 promotes the expression of Cblb mRNA (23) . In Jurkat cells treated with A23187, knockdown of DTX1 impaired the induction of Cbl-b (Fig. 6A) . Reintroduction of mouse DTX1 into DTX1-deficient Jurkat cells restored the expression of Cbl-b after A23187 treatment (Fig. 1B) . We observed that coexpression of DTX1 with Cbl-b in 293T cells led to increased protein level of Cbl-b (Fig. 6B) , suggesting that DTX1 also enhances the expression of Cbl-b at the protein level. Cbl-b protein stability was indeed decreased in anergic Jurkat cells with DTX1 knockdown (Supplemental Fig. 4B ). To exclude the possibility that DTX1-induced PKCu downregulation ( Fig. 1) was mediated by Cbl-b, Cbl-b was knocked down by specific shRNA in Jurkat cells, and the ability of DTX1 to downregulate PKCu was determined. Cbl-b deficiency did not affect DTX1-mediated degradation of PKCu in T cells (Fig. 6C) , suggesting that DTX1 may induce PKCu downregulation independently of Cbl-b.
We further studied whether there is an association between DTX1 and Cbl-b protein. In Jurkat T cells coexpressing DTX1-Myc and Cbl-b-Flag, precipitation with anti-Myc brought down Cbl-b (Fig. 7A) . Truncation of the C-terminal RING finger or the N-terminal two WWE domains from DTX1 did not affect its interaction with Cbl-b, whereas the deletion of proline-rich region impaired the binding of DTX1 to Cbl-b in Jurkat cells (Fig. 7A) , indicating that the proline-rich region is the Cbl-b-interacting segment. We also determined the DTX1-binding region on Cbl-b. Both N-terminal fragments and the middle regions of Cbl-b interacted with DTX1-Myc (Fig. 7B) , suggesting the RF domain is the major DTX1-binding area of Cbl-b. (Fig. 8A) . DTX1-Cbl-b interaction was further increased in anergic T cells. The PKCu is known to promote the degradation of Cbl-b protein (15) . We found that coexpression of Cbl-b with increasing amounts of PKCu led to proportional decreases in Cbl-b (Fig. 8B) . In Jurkat cells, A23187-induced Cbl-b upregulation was greatly enhanced by PKCu knockdown (Fig. 8C) , supporting a physiological role of PKCu in regulating Cbl-b protein levels (15) . Based on our observation that DTX1 induced the downregulation of PKCu, we examined whether DTX1 might protect the protein levels of Cbl-b from the action of PKCu through DTX1-induced PKCu degradation. Fig. 8D illustrates that PKCu-induced Cbl-b degradation was prevented by increasing amounts of DTX1, which correlated with a proportional decrease in PKCu. We further showed that T cell anergyinduced association of endogenous DTX1, Cbl-b, and PKCu. Precipitation of PKCu did not bring down DTX1 or Cbl-b in untreated Jurkat cells, but effectively pulled down both DTX1
and Cbl-b in A23187-treated Jurkat cells (Fig. 8E) , supporting the formation of complex containing DTX1, Cbl-b, and PKCu in anergic T cells. In addition, in PKCu-knockdown T cells, DTX1 no longer exhibited stabilization effect on Cbl-b protein (Fig. 8F) . Therefore, DTX1 may increase the stability of Cbl-b protein partly by promoting the degradation of PKCu.
Discussion
T cell anergy is attained by the upregulation of several ubiquitin E3 ligases that suppress T cell activation by inactivating signaling molecules. Both Cbl-b and Itch have been shown to promote PKCu and PLC-g1 degradation in anergic Th1 cells (7), whereas deficiency in Cbl-b or Itch affects anergy-associated downregulation of PKCu and PLC-g1. In addition, both Cbl-b and Itch induce PKCu degradation by directing PKCu to the endocytic pathway for lysosomal degradation (7). In the current study, we identified that PKCu and PLC-g1 are also downregulated by DTX1. DTX1 induces PKCu degradation in processes similar to those of Cbl-b and Itch: DTX1 promoted the monoubiquitination of PKCu and enhanced the relocalization of PKCu into endosomes and lysosomes (Figs. 3, 4) . We further showed that anergy-induced PKCu degradation was impaired in Dtx1 2/2 Th1 cells ( Fig. 5B) , indicating that DTX1 is also essential for PKCu degradation.
The involvement of three different E3 ligases in the downregulation of PKCu in anergic T cells is consistent with the critical role of PKCu in T cell activation (24) . PKCu is highly expressed in T cells. PKCu is the kinase that mediates TCR/CD28-triggered NF-kB signaling and NFAT activation (25, 26) . PKCu is the only PKC localized in immunological synapses in activated T cells, and PKCu controls the dynamics and stability of immunological synapses (27) . The localization of PKCu into the immunological synapse has been correlated with its capacity to bind CD28 (28), illustrating how PKCu integrates signals from TCR and CD28 (25) . PKCu contributes to Th2-and Th17-mediated inflammation and pathogenesis (15, 28) . Importantly, deficiency in PKCu leads to T cell anergy (29) . PKCu has been a therapeutic target in the control of autoimmunity and alloreactivity (24) .
One likely consequence of DTX1-induced PKCu degradation is the increased Cbl-b protein in anergic T cells (Fig. 6A) . PKCu antagonizes the action of Cbl-b during T cell activation by phosphorylating Cbl-b, which sensitizes Cbl-b for ubiquitination and degradation (15) . We have found that proline-rich regions of DTX1 interacted with PKCu ( Fig. 2) and bound Cbl-b (Fig. 7A) . Together with the reported association between Cbl-b and PKCu, the three-way interaction between DTX1, Cbl-b, and PKCu was confirmed in anergic T cells (Fig. 8E) . We found that DTX1 was constitutively associated with Cbl-b in untreated T cells (Fig. 8A) , in contrast to the Cbl-b-PKCu interaction detected after TCR/ CD28 activation or anergy induction (15) (Fig. 8E) . The complex of DTX1-Cbl-b-PKCu presumably could be formed after TCR activation in all T cells. However, DTX1 is immediately downregulated after TCR/CD28 engagement in regular T cell activation (22) . We propose that only in anergic T cells is the upregulation of DTX1 sufficient for DTX1-Cbl-b-PKCu complex formation and PKCu degradation.
An unexpected finding is the upregulation of endogenous DTX1 in Cbl-b-knockdown T cells (Supplemental Fig. 4A ). We attempted but have not identified the exact mechanism attributes to the enhanced expression of DTX1 caused by Cbl-b deficiency. However, this may help explain the observation that DTX1 triggered PKCu degradation in Cbl-b-deficient T cells (Fig. 6C) , as the excess DTX1 may compensate for the absence of Cbl-b, suggesting that the observed PKCu degradation could be a con- sequence of DTX1 overexpression. Whether DTX1 is capable of promoting PKCu degradation in Cbl-b-independent manner in physiological condition remains to be determined. Cbl-b, Itch, and DTX1 are involved in T cell anergy, but the crosstalk between these E3 ligases remain largely uncharacterized. Overexpressed Itch displays the ability to trigger the degradation of Cbl-b and DTX1 (30) (31) (32) . Whether Itch is accessible to Cbl-b and DTX1 in anergic T cells and negatively regulates Cbl-b and DTX1 remains to be demonstrated. DTX1 has been shown to promote the expression of Cblb mRNA (23) . In this study, we further found that DTX1 interacted with Cbl-b and enhanced the protein levels of Cbl-b. Our results therefore suggest the coordination between two E3 ligases in T cell anergy: both DTX1 and Cbl-b promotes PKCu downregulation, whereas DTX1 further enhances Cbl-b protein expression by antagonizing PKCu-mediated Cbl-b degradation.
Some of the T cell activation signaling are different between that DTX1 contributes to some of the anergic role of Cbl-b in T cells. Recent studies reveal many regulatory functions of Cbl-b, including anergy induction in B cells and NKT cells, antitumor T cell immunity, and activation of mast cells and macrophages (34, 35) . Whether DTX1 is also involved in the stabilization of Cbl-b in these functional activities deserves further investigation. The deficiency of any one of Cbl-b, Itch (7), or DTX1 (Fig. 5B ) affects anergy-induced degradation of PKCu in Th1 cells. We further found that A23187-triggered PKCu downregulation was impaired by DTX1 knockdown, Cbl-b knockdown, or Itch knockdown in Jurkat cells (Fig. 3D) . This was correlated with a reduction in PKCu monoqubiquitination in anergic Jurkat cells deficient in DTX1, Cbl-b, or Itch (Fig. 3D) . The nonredundant role of Cbl-b, Itch, and DTX1 in PKCu downregulation suggests that each E3 ligase acts through different essential mechanisms or participates in the different stages of the PKCu proteolysis pathway in anergic T cells. Interestingly, DTX1 promotes Notch monoubiquitination and directs Notch into the early endosome (21) , whereas the presence of Itch then relocalizes Notch to the multivesicular body for degradation (36) , demonstrating the differential contribution of two E3 ligases to Notch downregulation along the endocytic processes. Whether DTX1, Cbl-b, and Itch may participate in the different stages of endosome-lysosome pathway in the proteolysis of PKCu is currently being delineated.
In summary, we have found that DTX1, similar to Cbl-b and Itch, participates in T cell anergy-induced PKCu degradation. In addition, there is a coupling of DTX1 to Cbl-b in T cell anergy.
DTX1 is constitutively associated with Cbl-b and T cell anergytriggered additional recruitment of PKCu, leading to PKCu degradation. The present study thus suggests a new pathway in E3 ligase-mediated degradation of signaling molecules in anergic T cells. Our results also raise several questions that remain to be answered. A primary issue is on the exact molecular processes that DTX1, Cbl-b, and Itch participate in PKCu degradation, as anergyinduced PKCu degradation is compromised by deficiency in any one of the three E3 ligases. In addition, we have yet provided the direct evidences that DTX1-Cbl-b coordination in anergic T cell is operated in vivo. Further characterization will help resolve these issues for a clearer understanding of the molecular mechanisms underlying T cell anergy.
